1. 5 FDA approval decisions to watch for in Q4 — Can general practitioners survive COVID-19? — 7 former FDA commissioners write opinion column lamenting White House's treatment of agency — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Wujey Board

Discussion in 'Andrx Laboratories' started by Anonymous, Apr 10, 2011 at 11:23 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), today announced that Dr. James F. Lynch, formerly a member of the Company's Scientific Advisory Board, has been appointed President and Chief Executive Officer of PhytoMedical, effective March 15, 2010. Mr. Greg Wujek, PhytoMedical's outgoing President and CEO, continues to serve as Director on the Company's Board.